These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 7733983

  • 1. Aspartate-based inhibitor of interleukin-1 beta-converting enzyme prevents antitumor agent-induced apoptosis in human myeloid leukemia U937 cells.
    Mashima T, Naito M, Kataoka S, Kawai H, Tsuruo T.
    Biochem Biophys Res Commun; 1995 Apr 26; 209(3):907-15. PubMed ID: 7733983
    [Abstract] [Full Text] [Related]

  • 2. [Involvement of ICE/CED 3 family proteases in antitumor agent-induced apoptosis].
    Mashima T, Tsuruo T.
    Gan To Kagaku Ryoho; 1997 Jan 26; 24(2):211-5. PubMed ID: 9030233
    [Abstract] [Full Text] [Related]

  • 3. Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line.
    Tamura T, Ueda S, Yoshida M, Matsuzaki M, Mohri H, Okubo T.
    Biochem Biophys Res Commun; 1996 Dec 04; 229(1):21-6. PubMed ID: 8954078
    [Abstract] [Full Text] [Related]

  • 4. Actin cleavage by CPP-32/apopain during the development of apoptosis.
    Mashima T, Naito M, Noguchi K, Miller DK, Nicholson DW, Tsuruo T.
    Oncogene; 1997 Mar 06; 14(9):1007-12. PubMed ID: 9070648
    [Abstract] [Full Text] [Related]

  • 5. Resistance to antitumor agent-induced apoptosis in a mutant of human myeloid leukemia U937 cells.
    Kataoka S, Naito M, Tomida A, Tsuruo T.
    Exp Cell Res; 1994 Nov 06; 215(1):199-205. PubMed ID: 7957669
    [Abstract] [Full Text] [Related]

  • 6. Identification of actin as a substrate of ICE and an ICE-like protease and involvement of an ICE-like protease but not ICE in VP-16-induced U937 apoptosis.
    Mashima T, Naito M, Fujita N, Noguchi K, Tsuruo T.
    Biochem Biophys Res Commun; 1995 Dec 26; 217(3):1185-92. PubMed ID: 8554575
    [Abstract] [Full Text] [Related]

  • 7. Activation of actin-cleavable interleukin 1beta-converting enzyme (ICE) family protease CPP-32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells.
    Chen Z, Naito M, Mashima T, Tsuruo T.
    Cancer Res; 1996 Nov 15; 56(22):5224-9. PubMed ID: 8912861
    [Abstract] [Full Text] [Related]

  • 8. [The role of mitochondria in apoptosis in U937 and Molt-4 cells: difference in order of mitochondrial membrane potential (delta psi m) reduction and interleukin-1 beta-converting enzyme (ICE) on signal transduction pathway in each cell type].
    Kawaguchi M, Nakamura A, Tsurusawa M.
    Gan To Kagaku Ryoho; 1999 Apr 15; 26(5):679-85. PubMed ID: 10234300
    [Abstract] [Full Text] [Related]

  • 9. Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
    Eymin B, Dubrez L, Allouche M, Solary E.
    Cancer Res; 1997 Feb 15; 57(4):686-95. PubMed ID: 9044846
    [Abstract] [Full Text] [Related]

  • 10. c-Jun NH2-terminal kinase-mediated activation of interleukin-1beta converting enzyme/CED-3-like protease during anticancer drug-induced apoptosis.
    Seimiya H, Mashima T, Toho M, Tsuruo T.
    J Biol Chem; 1997 Feb 14; 272(7):4631-6. PubMed ID: 9020192
    [Abstract] [Full Text] [Related]

  • 11. U937 apoptotic cell death by nitric oxide: Bcl-2 downregulation and caspase activation.
    Brockhaus F, Brüne B.
    Exp Cell Res; 1998 Jan 10; 238(1):33-41. PubMed ID: 9457054
    [Abstract] [Full Text] [Related]

  • 12. p53-induced apoptosis in the human T-ALL cell line CCRF-CEM.
    Geley S, Hartmann BL, Hattmannstorfer R, Löffler M, Ausserlechner MJ, Bernhard D, Sgonc R, Strasser-Wozak EM, Ebner M, Auer B, Kofler R.
    Oncogene; 1997 Nov 13; 15(20):2429-37. PubMed ID: 9395239
    [Abstract] [Full Text] [Related]

  • 13. [The mechanism of apoptosis induced by anticancer agents in human leukemia cells].
    Yoshida A, Ueda T.
    Nihon Rinsho; 1996 Jul 13; 54(7):1822-7. PubMed ID: 8741673
    [Abstract] [Full Text] [Related]

  • 14. [The mechanism of apoptosis induced by anticancer agents in human leukemia HL-60 cells].
    Yoshida A, Ueda T, Nakamura T.
    Rinsho Ketsueki; 1996 Jul 13; 37(7):552-7. PubMed ID: 8779771
    [Abstract] [Full Text] [Related]

  • 15. Distinct steps in DNA fragmentation pathway during camptothecin-induced apoptosis involved caspase-, benzyloxycarbonyl- and N-tosyl-L-phenylalanylchloromethyl ketone-sensitive activities.
    Sané AT, Bertrand R.
    Cancer Res; 1998 Jul 15; 58(14):3066-72. PubMed ID: 9679972
    [Abstract] [Full Text] [Related]

  • 16. DNA fragmentation induced by protease activation in p53-null human leukemia HL60 cells undergoing apoptosis following treatment with the topoisomerase I inhibitor camptothecin: cell-free system studies.
    Shimizu T, Pommier Y.
    Exp Cell Res; 1996 Aug 01; 226(2):292-301. PubMed ID: 8806433
    [Abstract] [Full Text] [Related]

  • 17. The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells.
    Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM.
    Cancer Res; 1997 Sep 01; 57(17):3823-9. PubMed ID: 9288794
    [Abstract] [Full Text] [Related]

  • 18. The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line.
    Mese H, Sasaki A, Nakayama S, Alcalde RE, Matsumura T.
    Cancer Chemother Pharmacol; 2000 Sep 01; 46(3):241-5. PubMed ID: 11021742
    [Abstract] [Full Text] [Related]

  • 19. Topoisomerase inhibitor camptothecin sensitizes mouse hepatocytes in vitro and in vivo to TNF-mediated apoptosis.
    Hentze H, Latta M, Künstle G, Dhakshinamoorthy S, Ng PY, Porter AG, Wendel A.
    Hepatology; 2004 May 01; 39(5):1311-20. PubMed ID: 15122760
    [Abstract] [Full Text] [Related]

  • 20. B cell receptor cross-linking prevents Fas-induced cell death by inactivating the IL-1 beta-converting enzyme protease and regulating Bcl-2/Bcl-x expression.
    Brás A, Martinez-A C, Baixeras E.
    J Immunol; 1997 Oct 01; 159(7):3168-77. PubMed ID: 9317114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.